Soy Story -- References
To ensure the highest quality of content, we use only the latest and most complete primary research the medical community has to offer. All content written and researched by RealAge, Inc., has been peer-reviewed by members of the RealAge Scientific Advisory Board.
References
Effects of isoflavones (soy phyto-estrogens) on serum lipids: a meta-analysis of randomized controlled trials. Yeung, J., Yu, T. F., Nutrition Journal 2003 Nov 19;2(1):15.
Isoflavone-rich or isoflavone-poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. St. Germain, A. et al., Menopause 2001 Jan-Feb;8(1):17-26.
Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Alekel, D. L. et al., American Journal of Clinical Nutrition 2000;72(3):844-852.
Genistein inhibits the growth of human-patient BPH and prostate cancer in histoculture. Geller, J. et al., Prostate 1998 Feb 1;34(2):75-79.
Legumes and soybeans: overview of their nutritional profiles and health effects. Messina, M. J., American Journal of Clinical Nutrition 1999 Sep;70(3 Suppl):439S-450S.
Soy for the treatment of perimenopausal symptoms -- a systematic review. Huntley, A. L., Ernst, E., Maturitas 2004 Jan 20;47(1):1-9.
Soy protein with isoflavones, but not an isoflavone-rich supplement, improves arterial low-density lipoprotein metabolism and atherogenesis. Wagner, J. D. et al., Arteriosclerosis, Thrombosis, and Vascular Biology 2003 Dec;23(12):2241-2246.
The role of soy products in reducing risk of cancer. Messina, M., Barnes, S., Journal of the National Cancer Institute 1991 Apr 17;83(8):541-546.
Variations in isoflavone levels in soy foods and soy protein isolates and issues related to isoflavone databases and food labeling. Setchell, K. D., Cole, S. J., Journal of Agricultural and Food Chemistry 2003 Jul 2;51(14):4146-4155.
